Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
TANDEM DIABETES CARE INC (TNDM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/03/2018 |
GN
| Investor Expectations to Drive Momentum within Virtu Financial, Fate Therapeutics, Tandem Diabetes Care, Eli Lilly, Griffon, and Coherus BioSciences — Discovering Underlying Factors of Influence |
| 10/24/2018 |
GN
| Analysis: Positioning to Benefit within Spectrum Pharmaceuticals, Carnival, Cadence Design, Tandem Diabetes Care, Rigel Pharmaceuticals, and Regeneron Pharmaceuticals — Research Highlights Growth, Revenue, and Consolidated Results |
| 06/12/2018 |
GN
| Report: Developing Opportunities within ConocoPhillips, Teleflex, Enterprise Products Partners, Tandem Diabetes Care, J.B. Hunt Transport Services, and Ascena Retail Group — Future Expectations, Projections Moving into 2018 |
| 02/16/2018 |
GN
| Report: Exploring Fundamental Drivers Behind Life Storage, Suburban Propane Partners, DCT Industrial Trust, United Continental, Tandem Diabetes Care, and Crown Castle International — New Horizons, Emerging Trends, and Upcoming Developments |
| 12/04/2017 |
GN
| Report: Developing Opportunities within United Continental, Tandem Diabetes Care, Cavium, Life Storage, Suburban Propane Partners, and DCT Industrial Trust — Future Expectations, Projections Moving into 2018 |
| 11/02/2017 |
GN
| Analysis: Positioning to Benefit within Tandem Diabetes Care, CASI Pharmaceuticals, SAExploration, Roka Bioscience, VirnetX, and PhaseRx – Research Highlights Growth, Revenue, and Consolidated Results |
|
|